CURRENT PRINT ISSUE
Volume 8 Issue 8
Subscriber Services>>
Welcome, Guest Log in Endocrine Today
BlogsnewswireRSSMobileVideoPodcastsNews on the GoEndocrinology CME Center
Search
  • Diabetes and Metabolism
    • Type 1 diabetes
    • Type 2 diabetes
    • Gestational diabetes
    • Hyperglycemia and hypoglycemia
    • Glycemic control
    • Diabetic therapeutic agents
    • Obesity and bariatric surgery
    • Cross-cultural care
    • Diabetic comorbidities
    • Patient management
  • Pediatric Endocrinology
    • Type 1 diabetes
    • Hyperglycemia and hypoglycemia
    • Growth hormone therapy
    • Diabetic therapeutic agents
    • Obesity
    • Cross-cultural care
    • Diabetic comorbidities
    • Gender identity disorders
  • Thyroid
    • Thyroid cancer
    • Thyroid-stimulating hormone
    • Hypothyroidism
    • Hyperthyroidism
    • Thyroid nodules
    • Parathyroid
    • Thyrogenous scanning
  • Cardiometabolic Disorders
    • Cardiovascular disease
    • Hypertension and hypotension
    • Metabolic syndrome
    • Myocardial infarction
    • Atherosclerosis
    • Hyperlipidemia
    • Stroke
    • Coronary heart disease
  • Hormone Therapy
    • Hormone replacement therapy
    • Estrogen therapy
    • Testosterone therapy
    • Growth hormone therapy
    • Anabolic steroid abuse
    • Gender identity disorders
    • Menopause
  • Bone and Mineral Metabolism
    • Osteoporosis and fractures
    • Osteonecrosis of the jaw
    • Bone mineral density
    • Calcium and vitamin D supplementation
  • Neuroendocrinology
    • Idiopathic short stature
    • Pituitary
    • IGF-I levels
  • Adrenal
    • HPA axis
    • Noncongenital adrenal hyperplasia
    • Congenital adrenal hyperplasia
    • Pheochromocytoma
  • Reproduction and Androgen Disorders
    • PCOS
    • Hyperandrogenism
    • Androgen deficiency
    • Menopause
    • Cross-cultural care
  • Features
  • Meeting Highlights
  • In the Journals
  • Meet the Editorial Board
  • Resource Center:
    Type 2 Diabetes
    Kathleen M. Dungan, MD Viewpoint: Cardiovascular risk management in type 2 diabetes, screening and education

    Endocrine Today interviews Kathleen M. Dungan, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, & Metabolism, at Ohio State University in Columbus, Ohio. Part 2 of a 2-part series.
    Click here

< Previous Issues

The following online articles appeared in the August 1, 2010 print edition of Endocrine Today.

Proposed guidelines would expand osteoporosis screening

Upcoming study will target optimal treatment of diabetic ketoacidosis

FDA: Avoid unintentional exposure of children, pets to estrogen spray

How do you rank and use medical evidence?

FDA panel recommendation creates mixed opinions about future of rosiglitazone

Barriers to achieving targets, risks of hyperglycemia and hypoglycemia in children

Postmarketing drug safety surveillance: Is enough being done?

Parathyroidectomy thyroiditis and thyrotoxicosis

Glucokinase activators offer a potentially promising therapeutic approach for type 2 diabetes

Treating prediabetes: An overlooked opportunity?

 

 

Register Login Contact Us Help Advertising Information About Us Supporters Links
Privacy Policy
Copyright © 2010 SLACK, Inc. All Rights Reserved.